The U.S. Food and Drug Administration is limiting the use of Johnson and Johnson's Janssen COVID-19 vaccine as a last resort for adults who cannot accept a shot from another manufacturer:
The US Food and Drug Administration and the Centers for Disease Control and Prevention confirmed a total of 60 cases in which the J&J, Janssen vaccine resulted in rare and potentially life-threatening blood clots.
The U.S. Food and Drug Administration is limiting the use of Johnson and Johnson's Janssen COVID-19 vaccine as a last resort for adults who cannot accept a shot from another manufacturer. Though the potential benefits of the vaccine outweigh the risks, the FDA said Thursday that it is restricting the use of the Janssen vaccine. It will be limited to individuals 18 and older and medically ineligible for another approved vaccine and to those who only have access to the J&J vaccine and want one, according to anResearchers with the FDA and Centers for Disease Control and Prevention found that the vaccine resulted in 60 confirmed cases of thrombosis with thrombocytopenia syndrome.
"Today's action demonstrates the robustness of our safety surveillance systems and our commitment to ensuring that science and data guide our decisions. We've been closely monitoring the Janssen COVID-19 vaccine and occurrence of TTS following its administration and have used updated information from our safety surveillance systems to revise the EUA," said Peter Marks, director of the FDA's Center for Biologics Evaluation and Research.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA puts strict limits on Johnson & Johnson Covid-19 vaccineThe US Food and Drug Administration announced Thursday that it is limiting the emergency use authorization of the Johnson & Johnson/Janssen Covid-19 vaccine to people 18 and older for whom other vaccines aren't appropriate or accessible and those who opt for J&J because they wouldn't otherwise get vaccinated.
Read more »
FDA announces limits on who can receive Johnson & Johnson COVID-19 vaccineThe reason is a rare, but serious risk of blood clots.
Read more »
FDA restricts Johnson & Johnson COVID-19 vaccine due to blood clot riskThe Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine.
Read more »
FDA restricts use of Johnson & Johnson COVID vaccine due to blood clot riskThe Food and Drug Administration put rigid limits on who can receive Johnson & Johnson’s one-dose COVID-19 vaccine on Thursday, saying the vaccine should only be given to people who cannot receive a different vaccine or those who specifically request it.
Read more »
FDA restricts Johnson & Johnson's COVID-19 vaccine due to blood clot riskU.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots.
Read more »
FDA restricts Johnson & Johnson's COVID-19 vaccine due to rare but serious risk of blood clotsU.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
Read more »